Bumper Offer - Urjas oil Just @ Rs. 1
Diligan 25 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Nausea and Vomiting. Diligan 25 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Diligan 25 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Diligan 25 Tablet have been listed ahead. Usually, these side effects of Diligan 25 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Diligan 25 Tablet is Safe for pregnant women and Moderate for women who are breastfeeding. Further, the section on Diligan 25 Tablet related warnings talks about Diligan 25 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Glaucoma must refrain from the use of Diligan 25 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Diligan 25 Tablet are listed in the contraindications section below.
Drug interactions for Diligan 25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Diligan 25 Tablet is considered not safe while driving, and is not addictive.
Diligan 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Diligan 25 Tablet is used -
Moderate
Mild
Unknown
Is the use of Diligan 25 Tablet safe for pregnant women?
Pregnant women can take Diligan safely.
Is the use of Diligan 25 Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Diligan. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Diligan 25 Tablet on the Kidneys?
Very few cases of side effects of Diligan on kidney have been reported.
What is the effect of Diligan 25 Tablet on the Liver?
Side effects of Diligan rarely affect the liver.
What is the effect of Diligan 25 Tablet on the Heart?
You can take Diligan without any fear of damage to the heart.
Diligan 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diligan 25 Tablet unless your doctor advises you to do so -
Is this Diligan 25 Tablet habit forming or addictive?
No, there is no any evidence that Diligan 25 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Diligan 25 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but take Diligan 25 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Diligan 25 Tablet is not used to treat mental disorders.
Interaction between Food and Diligan 25 Tablet
Taking Diligan 25 Tablet with food does not cause any problems.
Interaction between Alcohol and Diligan 25 Tablet
Consuming Diligan 25 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Antivert® (meclizine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 46-47
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Antivert® (meclizine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 46-47
